356 related articles for article (PubMed ID: 31731545)
1. Recent Advances in Basic Research for Brain Arteriovenous Malformation.
Barbosa Do Prado L; Han C; Oh SP; Su H
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31731545
[TBL] [Abstract][Full Text] [Related]
2. Review of treatment and therapeutic targets in brain arteriovenous malformation.
Pan P; Weinsheimer S; Cooke D; Winkler E; Abla A; Kim H; Su H
J Cereb Blood Flow Metab; 2021 Dec; 41(12):3141-3156. PubMed ID: 34162280
[TBL] [Abstract][Full Text] [Related]
3. Somatic mosaicism in the MAPK pathway in sporadic brain arteriovenous malformation and association with phenotype.
Gao S; Nelson J; Weinsheimer S; Winkler EA; Rutledge C; Abla AA; Gupta N; Shieh JT; Cooke DL; Hetts SW; Tihan T; Hess CP; Ko N; Walcott BP; McCulloch CE; Lawton MT; Su H; Pawlikowska L; Kim H
J Neurosurg; 2022 Jan; 136(1):148-155. PubMed ID: 34214981
[TBL] [Abstract][Full Text] [Related]
4. Association of common candidate variants with vascular malformations and intracranial hemorrhage in hereditary hemorrhagic telangiectasia.
Pawlikowska L; Nelson J; Guo DE; McCulloch CE; Lawton MT; Kim H; Faughnan ME;
Mol Genet Genomic Med; 2018 May; 6(3):350-356. PubMed ID: 29932521
[TBL] [Abstract][Full Text] [Related]
5. Hemorrhage rates from brain arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia.
Kim H; Nelson J; Krings T; terBrugge KG; McCulloch CE; Lawton MT; Young WL; Faughnan ME;
Stroke; 2015 May; 46(5):1362-4. PubMed ID: 25858236
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of non-hereditary brain arteriovenous malformation and therapeutic implications.
Ota T; Komiyama M
Interv Neuroradiol; 2020 Jun; 26(3):244-253. PubMed ID: 32024399
[TBL] [Abstract][Full Text] [Related]
7. Reductions in brain pericytes are associated with arteriovenous malformation vascular instability.
Winkler EA; Birk H; Burkhardt JK; Chen X; Yue JK; Guo D; Rutledge WC; Lasker GF; Partow C; Tihan T; Chang EF; Su H; Kim H; Walcott BP; Lawton MT
J Neurosurg; 2018 Dec; 129(6):1464-1474. PubMed ID: 29303444
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the vascular labyrinth: role of microRNAs and candidate gene SNPs in brain AVM development - literature review.
Florian IA; Timiș TL; Ungureanu G; Florian IS; Bălașa A; Berindan-Neagoe I
Neurol Res; 2020 Dec; 42(12):1043-1054. PubMed ID: 32723034
[No Abstract] [Full Text] [Related]
9. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis.
Brinjikji W; Iyer VN; Wood CP; Lanzino G
J Neurosurg; 2017 Aug; 127(2):302-310. PubMed ID: 27767404
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide Reduces Hemorrhage of Brain Arteriovenous Malformations in a Mouse Model.
Zhu W; Chen W; Zou D; Wang L; Bao C; Zhan L; Saw D; Wang S; Winkler E; Li Z; Zhang M; Shen F; Shaligram S; Lawton M; Su H
Stroke; 2018 May; 49(5):1232-1240. PubMed ID: 29593101
[TBL] [Abstract][Full Text] [Related]
11. Selective Endothelial Hyperactivation of Oncogenic KRAS Induces Brain Arteriovenous Malformations in Mice.
Park ES; Kim S; Huang S; Yoo JY; Körbelin J; Lee TJ; Kaur B; Dash PK; Chen PR; Kim E
Ann Neurol; 2021 May; 89(5):926-941. PubMed ID: 33675084
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for hemorrhage of brain arteriovenous malformation.
Shaligram SS; Winkler E; Cooke D; Su H
CNS Neurosci Ther; 2019 Oct; 25(10):1085-1095. PubMed ID: 31359618
[TBL] [Abstract][Full Text] [Related]
13. The CTSC-RAB38 Fusion Transcript Is Associated With the Risk of Hemorrhage in Brain Arteriovenous Malformations.
Yan Z; Fan G; Li H; Jiao Y; Fu W; Weng J; Huo R; Wang J; Xu H; Wang S; Cao Y; Zhao J
J Neuropathol Exp Neurol; 2021 Jan; 80(1):71-78. PubMed ID: 33120410
[TBL] [Abstract][Full Text] [Related]
14. Treatment of multiple arteriovenous malformations in pediatric patients with hereditary hemorrhagic telangiectasia and spontaneous hemorrhage. Report of two cases.
Kuo YH; Santoreneos S; Roos D; Brophy BP
J Neurosurg; 2007 Dec; 107(6 Suppl):489-94. PubMed ID: 18154019
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation and treatment paradigms of brain arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia.
Gamboa NT; Joyce EJ; Eli I; Park MS; Taussky P; Schmidt RH; McDonald J; Whitehead KJ; Kalani MYS
J Clin Neurosci; 2018 May; 51():22-28. PubMed ID: 29483005
[TBL] [Abstract][Full Text] [Related]
16. Leptin plays a role in ruptured human brain arteriovenous malformations.
Xie Q; Chen XC; Gong Y; Gu YX
Acta Neurochir Suppl; 2008; 105():221-4. PubMed ID: 19066113
[TBL] [Abstract][Full Text] [Related]
17. Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.
Zhang R; Zhu W; Su H
Acta Neurochir Suppl; 2016; 121():29-35. PubMed ID: 26463919
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-2 Inhibition Rescues Arteriovenous Malformation in a Smad4 Hereditary Hemorrhagic Telangiectasia Mouse Model.
Crist AM; Zhou X; Garai J; Lee AR; Thoele J; Ullmer C; Klein C; Zabaleta J; Meadows SM
Circulation; 2019 Apr; 139(17):2049-2063. PubMed ID: 30744395
[TBL] [Abstract][Full Text] [Related]
19. Somatic Mosaicism in the Pathogenesis of de novo Cerebral Arteriovenous Malformations: A Paradigm Shift Implicating the RAS-MAPK Signaling Cascade.
Peterson K; Coffman S; Zehri A; Anzalone A; Xiang Z; Wolfe S
Cerebrovasc Dis; 2021; 50(2):231-238. PubMed ID: 33556951
[TBL] [Abstract][Full Text] [Related]
20. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
